ApoA-I/HDL generation and intracellular cholesterol transport through cytosolic lipid-protein particles in astrocytes

Journal of Lipids

Volumn 2014, Issue , 2014, Pages

  Ito, Jinichi ^a   Michikawa, Makoto ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL; CYTOSOLIC LIPID PROTEIN PARTICLE; HIGH DENSITY LIPOPROTEIN; LIPID; PROTEIN; PROTEIN KINASE C ALPHA; SPHINGOMYELIN; UNCLASSIFIED DRUG;

ASTROCYTE; BRAIN; CELL MEMBRANE; CHOLESTEROL TRANSPORT; HUMAN; INTRACELLULAR TRANSPORT; MICROTUBULE; NONHUMAN; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 85039881920     PISSN: 20903030     EISSN: 20903049     Source Type: Journal    
DOI: 10.1155/2014/530720     Document Type: Review

References (75)

1. G. Assmann, A. M. Gotto, and M. DPhil, "HDL cholesterol and protective factors in atherosclerosis," Circulation, vol. 109, supplement 3, pp. 8-14, 2004.
2. P. Barter, "The role of HDL-cholesterol in preventing atherosclerotic disease," European Heart Journal, Supplement, vol. 7, pp. F4-F8, 2005.
3. U. Ravnskov, "Is atherosclerosis caused by high cholesterol?" Oxford Journals Medicine, vol. 95, no. 6, pp. 397-403, 2002.
4. M. E. Brousseau, G. P. Eberhart, J. Dupuis et al., "Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size," Journal of Lipid Research, vol. 41, no. 7, pp. 1125-1135, 2000.
5. A. T. Remaley, U. K. Schumacher, J. A. Stonik et al., "Decreased reverse cholesterol transport from Tangier Disease fibroblasts," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, pp. 1813-1821, 1997.
6. T. Chang, P. C. Reid, S. Sugii, N. Ohgami, J. C. Cruz, and C. C. Y. Chang, "Niemann-Pick type C disease and intracellular cholesterol trafficking," Journal of Biological Chemistry, vol. 280, no. 22, pp. 20917-20920, 2005.
7. M. Kosicek, M. Malnar, A. Goate, and S. Hecimovic, "Cholesterol accumulation in Niemann Pick type C (NPC) model cells causes a shift in APP localization to lipid rafts," Biochemical and Biophysical Research Communications, vol. 393, no. 3, pp. 404-409, 2010.
8. N. Arispe and M. Doh, "Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AßP (1-40) and (1-42) peptides," The FASEB Journal, vol. 16, no. 12, pp. 1526-1536, 2002.
9. M. Michikawa, "Cholesterol paradox: Is high total or low HDL cholesterol level a risk for Alzheimer's disease?" Journal of Neuroscience Research, vol. 72, no. 2, pp. 141-146, 2003.
10. R. A. Cooper, "Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells," Journal of Supramolecular and Cellular Biochemistry, vol. 8, no. 4, pp. 413-430, 1978.
11. S. Raffy and J. Teissié, "Control of lipid membrane stability by cholesterol content," Biophysical Journal, vol. 76,no. 4, pp. 2072-2080, 1999.
12. K. B. Kannan, D. Barlos, and C. J. Hauser, "Free cholesterol alters lipid raft structure and function regulating neutrophil Ca2+ entry and respiratory burst: Correlations with calcium channel raft trafficking," Journal of Immunology, vol. 178, no. 8, pp. 5253-5261, 2007.
13. Z. Korade and A. K. Kenworthy, "Lipid rafts, cholesterol, and the brain," Neuropharmacology, vol. 55, no. 8, pp. 1265-1273, 2008.
14. J. L. Goldstein and M. S. Brown, "The LDL receptor," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 4, pp. 431-438, 2009.
15. R. Ohashi, H. Mu, X. Wang et al., "Reverse cholesterol transport and cholesterol efflux in atherosclerosi," Oxford Journals Medicine, vol. 98, pp. 845-856, 2005.
16. R. B. DeMattos, L. K. Curtiss, and D. L. Williams, "A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins," The Journal of Biological Chemistry, vol. 273, no. 7, pp. 4206-4212, 1998.
17. A. M. Fagan, G. Bu, Y. Sun, A. Daugherty, and D. M. Holtzman, "Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein," Journal of Biological Chemistry, vol. 271, no. 47, pp. 30121-30125, 1996.
18. H. Hayashi, R. B. Campenot, D. E. Vance, and J. E. Vance, "Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1," Journal of Neuroscience, vol. 27, no. 8, pp. 1933-1941, 2007.
19. D. H. Mauch, K. Nägier, S. Schumacher et al., "CNS synaptogenesis promoted by glia-derived cholesterol," Science, vol. 294, no. 5545, pp. 1354-1357, 2001.
20. M. F. Linton, R. Gish, S. T. Hubl et al., "Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation," Journal of Clinical Investigation, vol. 88, no. 1, pp. 270-281, 1991.
21. R. D. Bell, E. A. Winkler, I. Singh et al., "Apolipoprotein e controls cerebrovascular integrity via cyclophilin A," Nature, vol. 485, no. 7399, pp. 512-516, 2012.
22. K. Nishitsuji, T. Hosono, T. Nakamura, G. Bu, and M. Michikawa, "Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro bloodbrain barrier model," Journal of Biological Chemistry, vol. 286, no. 20, pp. 17536-17542, 2011.
23. J. K. Boyles, R. E. Pitas, E. Wilson, R. W. Mahley, and J. M. Taylor, "Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system," The Journal of Clinical Investigation, vol. 76, no. 4, pp. 1501-1513, 1985.
24. S. C. Fujita, K. Sakuta, R. Tsuchiya, and H. Hamanaka, "Apolipoprotein E is found in astrocytes but not in microglia in the normal mouse brain," Neuroscience Research, vol. 35, no. 2, pp. 123-133, 1999.
25. J. Ito, L. Y. Zhang, M. Asai, and S. Yokoyama, "Differential generation of high-density lipoprotein by endogenous and exogenous apolipoproteins in cultured fetal rat astrocytes," Journal of Neurochemistry, vol. 72, no. 6, pp. 2362-2369, 1999.
26. L. Zhang, J. Ito, T. Kato, and S. Yokoyama, "Cholesterol homeostasis in rat astrocytoma cells Ga-1," Journal of Biochemistry, vol. 128, no. 5, pp. 837-845, 2000.
27. I. Borghini, F. Barja, D. Pometta, and R. W. James, "Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid," Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, vol. 1255, no. 2, pp. 192-200, 1995.
28. H. Chiba, T. Mitamura, S.-. Fujisawa et al., "Apolipoproteins in rat cerebrospinal fluid: a comparison with plasma lipoprotein metabolism and effect of aging," Neuroscience Letters, vol. 133, no. 2, pp. 207-210, 1991.
29. S. Koch, N. Donarski, K. Goetze et al., "Characterization of four lipoprotein classes in human cerebrospinal fluid," Journal of Lipid Research, vol. 42, no. 7, pp. 1143-1151, 2001.
30. J. Ito, H. Li, Y. Nagayasu, A. Kheirollah, and S. Yokoyama, "Apolipoprotein A-I induces translocation of protein kinase Cα to a cytosolic lipid-protein particle in astrocytes," Journal of Lipid Research, vol. 45, no. 12, pp. 2269-2276, 2004.
31. J. Ito, Y. Nagayasu, K. Kato, R. Sato, and S. Yokoyama, "Apolipoprotein A-I induces translocation of cholesterol, phospholipid, and caveolin-1 to cytosol in rat astrocytes," Journal of Biological Chemistry, vol. 277, no. 10, pp. 7929-7935, 2002.
32. J. Ito, Y. Nagayasu, S. Ueno, and S. Yokoyama, "Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner," Journal of Biological Chemistry, vol. 277, no. 47, pp. 44709-44714, 2002.
33. N. A. Braun, P. J. Mohler, K. H. Weisgraber et al., "Intracellular trafficking of recycling apolipoprotein E in Chinese hamster ovary cells," Journal of Lipid Research, vol. 47, no. 6, pp. 1176-1186, 2006.
34. J. Deng, V. Rudick, and L. Dory, "Lysosomal degradation and sorting of apolipoprotein E in macrophages," Journal of Lipid Research, vol. 36, no. 10, pp. 2129-2140, 1995.
35. J. Heeren, T. Grewal, A. Laatsch et al., "Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation," Journal of Biological Chemistry, vol. 279, no. 53, pp. 55483-55492, 2004.
36. M. Kockx, D. L. Guo, T. Huby et al., "Secretion of apolipoprotein E from macrophages occurs via a protein kinase A- and calcium-dependent pathway along the microtubule network," Circulation Research, vol. 101, no. 6, pp. 607-616, 2007.
37. V. I. Zannis, J. McPherson, G. Goldberger, S. K. Karathanasis, and J. L. Breslow, "Synthesis, intracellular processing, and signal peptide of human apolipoprotein E," Journal of Biological Chemistry, vol. 259, no. 9, pp. 5495-5499, 1984.
38. Y. Zhao and T. Mazzone, "Transport and processing of endogenously synthesized ApoE on the macrophage cell surface," Journal of Biological Chemistry, vol. 275, no. 7, pp. 4759-4765, 2000.
39. J. Ito, Y. Nagayasu, Y. Miura, S. Yokoyama, and M. Michikawa, "Astrocytes's endogenous apoE generates HDL-like lipoproteins using previously synthesized cholesterol through interaction with ABCA1," Brain Research, vol. 1570, pp. 1-12, 2014.
40. D. A. Elliott, C. S. Weickert, and B. Garner, "Apolipoproteins in the brain: implications for neurological and psychiatric disorders," Journal of Clinical Lipidology, vol. 51, no. 4, pp. 555-573, 2010.
41. R. W. Mahley, "Apolipoprotein E: cholesterol transport protein with expanding role in cell biology," Science, vol. 240, no. 4852, pp. 622-630, 1988.
42. B. Möckel, H. Zinke, R. Flach, B. Weiß, H. Weiler-Güttler, and H. G. Gassen, "Expression of apolipoprotein A-I in porcine brain endothelium in vitro," Journal of Neurochemistry, vol. 62, no. 2, pp. 788-798, 1994.
43. H. Weiler-Guttler, M. Sommerfeldt, A. Papandrikopoulou et al., "Synthesis of apolipoprotein A-1 in pig brain microvascular endothelial cells," Journal of Neurochemistry, vol. 54, no. 2, pp. 444-450, 1990.
44. U. Panzenboeck, Z. Balazs, A. Sovic et al., "ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells," The Journal of Biological Chemistry, vol. 277, no. 45, pp. 42781-42789, 2002.
45. T. L. Lewis, D. Cao, H. Lu et al., "Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of alzheimer disease," The Journal of Biological Chemistry, vol. 285, no. 47, pp. 36958-36968, 2010.
46. C. Reitz, M. Tang, J. Luchsinger, and R. Mayeux, "Relation of plasma lipids to Alzheimer disease and vascular dementia," Archives of Neurology, vol. 61, no. 5, pp. 705-714, 2004.
47. R. Giudice, D. Monti, C. Sarcinelli, A. Arciello, R. Piccoli, and G. F. Hu, "Amyloidogenic variant of apolipoprotein A-I elicits cellular stress by atenuating the protective activity of angiogenin," Cell Death and Disease, vol. 5, Article ID e1097, 2014.
48. V. Hirsch-Reinshagen, S. Zhou, B. L. Burgess et al., "Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain," Journal of Biological Chemistry, vol. 279, no. 39, pp. 41197-41207, 2004.
49. R. Koldamova, M. Staufenbiel, and I. Lefterov, "Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice," The Journal of Biological Chemistry, vol. 280, no. 52, pp. 43224-43235, 2005.
50. L. Krimbou, M. Denis, B. Haidar, M. Carrier, M. Marcil, and J. Genest Jr., "Molecular interactions between apoE and ABCA1: impact on apoE lipidation," Journal of Lipid Research, vol. 45, no. 5, pp. 839-848, 2004.
51. S. E. Wahrle, H. Jiang, M. Parsadanian et al., "ABCA1 is required for normal central nervous system apoE levels and for lipidation of astrocyte-secreted apoE," Journal of Biological Chemistry, vol. 279, no. 39, pp. 40987-40993, 2004.
52. J. Ito, Y. Nagayasu, A. Kheirollah, S. Abe-Dohmae, and S. Yokoyama, "ApoA-I enhances generation of HDL-like lipoproteins through interaction between ABCA1 and phospholipase Cγ in rat astrocytes," Biochimica et Biophysica Acta, vol. 1811, no. 12, pp. 1062-1069, 2011.
53. K. M. Smith, R. M. Lawn, and J. N. Wilcox, "Cellular localization of apolipoprotein D and lecithin: cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization," Journal of Lipid Research, vol. 31, no. 6, pp. 995-1004, 1990.
54. M. Bodzioch, E. Orsó, J. Klucken et al., "The gene encoding ATP-binding cassette transporter I is mutated in Tangier disease," Nature Genetics, vol. 22, no. 4, pp. 347-351, 1999.
55. A. Brooks-Wilson, M. Marcil, S. M. Clee et al., "Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency," Nature Genetics, vol. 22, no. 4, pp. 336-345, 1999.
56. S. Rust, M. Rosier, H. Funke et al., "Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1," Nature Genetics, vol. 22, no. 4, pp. 352-355, 1999.
57. J. F. Oram, R. M. Lawn, M. R. Garvin, and D. P. Wade, "ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages," The Journal of Biological Chemistry, vol. 275, no. 44, pp. 34508-34511, 2000.
58. A. M. Vaughan and J. F. Oram, "ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions," Journal of Lipid Research, vol. 44, no. 7, pp. 1373-1380, 2003.
59. N. Wang, D. L. Silver, P. Costet, and A. R. Tall, "Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1," The Journal of Biological Chemistry, vol. 275, no. 42, pp. 33053-33058, 2000.
60. L. Yvan-Charvet, N. Wang, and A. R. Tall, "Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 2, pp. 139-143, 2010.
61. Y. D. Landry, M. Denis, S. Nandi, S. Bell, A. M. Vaughan, and X. Zha, "ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions," Journal of Biological Chemistry, vol. 281, no. 47, pp. 36091-36101, 2006.
62. W. Chen, Y. Sun, C. Welch et al., "Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes," The Journal of Biological Chemistry, vol. 276, no. 47, pp. 43564-43569, 2001.
63. Y. Takahashi and J. D. Smith, "Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway," Proceedings of the National Academy of Sciences of the United States of America, vol. 96,no. 20,pp. 11358-11363, 1999.
64. J. M. Sturek, J. D. Castle, A. P. Trace et al., "An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic β cells," Journal of Clinical Investigation, vol. 120, no. 7, pp. 2575-2589, 2010.
65. P. T. Tarr and P. A. Edwards, "ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2," Journal of Lipid Research, vol. 49, no. 1, pp. 169-182, 2008.
66. N. Wang, D. Lan, W. Chen, F. Matsuura, and A. R. Tall, "ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 26, pp. 9774-9779, 2004.
67. B. Karten, R. B. Campenot, D. E. Vance, and J. E. Vance, "Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia," The Journal of Biological Chemistry, vol. 281, no. 7, pp. 4049-4057, 2006.
68. A. Kheirollah, J. Ito, Y. Nagayasu, R. Lu, and S. Yokoyama, "Cyclosporin A inhibits apolipoprotein A-I-induced early events in cellular cholesterol homeostasis in rat astrocytes," Neuropharmacology, vol. 51, no. 4, pp. 693-700, 2006.
69. S. A. Pandit, S. Vasudevan, S. W. Chiu, R. J. Mashl, E. Jakobsson, and H. L. Scott, "Sphingomyelin-cholesterol domains in phospholipid membranes: atomistic simulation," Biophysical Journal, vol. 87, no. 2, pp. 1092-1100, 2004.
70. T. Róg and M. Pasenkiewicz-Gierula, "Cholesterol-sphingomyelin interactions: a molecular dynamics simulation study," Biophysical Journal, vol. 91, no. 10, pp. 3756-3767, 2006.
71. K. Simons and E. Ikonen, "Functional rafts in cell membranes," Nature, vol. 387, no. 6633, pp. 569-572, 1997.
72. J. Ito, Y. Nagayasu, and S. Yokoyama, "Cholesterol-sphingomyelin interaction in membrane and apolipoprotein- mediated cellular cholesterol efflux," Journal of Lipid Research, vol. 41, no. 6, pp. 894-904, 2000.
73. K. Nagao, K. Takahashi, K. Hanada, N. Kioka, M. Matsuo, and K. Ueda, "Enhanced ApoA-I-dependent cholesterol efflux by ABCA1 from sphingomyelin-deficient Chinese hamster ovary cells," The Journal of Biological Chemistry, vol. 282, no. 20, pp. 14868-14874, 2007.
74. J. Ito, A. Kheirollah, Y. Nagayasu, R. Lu, K. Kato, and S. Yokoyama, "Apolipoprotein A-I increases association of cytosolic cholesterol and caveolin-1 with microtubule cytoskeletons in rat astrocytes," Journal of Neurochemistry, vol. 97, no. 4, pp. 1034-1043, 2006.
75. J. Ito, R. Lu, Y. Nagayasu et al., "Apoprotein A-I induces tubulin phosphorylation in association with cholesterol release in fetal rat astrocytes," Biochimica Biophysica et Acta, 2014.